Hollings Cancer Center researcher awarded NIH - EurekAlert

“Cancer is rarely cured by targeting single genes with drugs. We identified that a certain pathway, the cadmium response pathway, is commonly suppressed in 70% of high-grade serous ovarian cancers. This pathway gives us a unique opportunity for studying the b…
image: Marty Romeo, Ph.D., left, director of the Translational Science Laboratory at Hollings, has provided assistance to Joe Delaney, Ph.D., in his creative search for new ways to target cancer.view… [+6981 chars] Read More